These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 16151589

  • 1. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
    Horácek JM, Pudil R, Tichý M, Jebavý L, Strasová A, Praus R, Zák P, Malý J.
    Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
    [Abstract] [Full Text] [Related]

  • 2. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
    Horacek JM, Pudil R, Tichy M, Jebavy L, Zak P, Slovacek L, Maly J.
    Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
    [Abstract] [Full Text] [Related]

  • 3. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
    Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J.
    Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
    [Abstract] [Full Text] [Related]

  • 4. [Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients].
    Qin J, Zhang PH, Qian XY, Kang SJ, Luo RC, Wang YG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):930-2. PubMed ID: 18583230
    [Abstract] [Full Text] [Related]

  • 5. N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.
    Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, Algur N, Weintraub M.
    J Pediatr Hematol Oncol; 2007 Jul; 29(7):440-4. PubMed ID: 17609620
    [Abstract] [Full Text] [Related]

  • 6. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency.
    Yamashita T, Seino Y, Ogawa A, Ogata K, Fukushima M, Tanaka K, Mizuno K.
    J Cardiol; 2010 May; 55(3):377-83. PubMed ID: 20350516
    [Abstract] [Full Text] [Related]

  • 7. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 May; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 8. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 9. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G, Corrado E, Mulè MC, Augugliaro S, Cucchiara A, Novo G, Amoroso G, Assennato P, Hoffmann E, Vitale F, Novo S.
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [Abstract] [Full Text] [Related]

  • 10. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):91-7. PubMed ID: 16386670
    [Abstract] [Full Text] [Related]

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 12. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM, Fahoum SK, Shamia MG.
    Clin Lab; 2007 Nov 13; 53(1-2):35-9. PubMed ID: 17323823
    [Abstract] [Full Text] [Related]

  • 13. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.
    J Heart Lung Transplant; 2006 Oct 13; 25(10):1230-40. PubMed ID: 17045936
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.
    Int J Cardiol; 2009 Jun 26; 135(2):165-74. PubMed ID: 18603317
    [Abstract] [Full Text] [Related]

  • 15. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.
    Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, Choi NC, Yock TI.
    Lung Cancer; 2008 Dec 26; 62(3):351-5. PubMed ID: 18462828
    [Abstract] [Full Text] [Related]

  • 16. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W, Ong-Ajyooth L, Taruangsri P, Pokum S.
    J Med Assoc Thai; 2003 May 26; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [Abstract] [Full Text] [Related]

  • 17. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines.
    Germanakis I, Kalmanti M, Parthenakis F, Nikitovic D, Stiakaki E, Patrianakos A, Vardas PE.
    Int J Cardiol; 2006 Apr 04; 108(2):212-5. PubMed ID: 16290101
    [Abstract] [Full Text] [Related]

  • 18. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A, Kaklamanis L, Ziras N, Sofroniadou S, Makaritsis K, Adamopoulos S, Revela I, Athanasiou A, Mavroudis D, Georgoulias V.
    Int J Cardiol; 2007 Nov 30; 122(3):195-201. PubMed ID: 17289172
    [Abstract] [Full Text] [Related]

  • 19. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
    Tedeschi A, Montillo M, Strocchi E, Cafro AM, Tresoldi E, Intropido L, Nichelatti M, Marbello L, Baratè C, Camaggi CM, Morra E.
    Cancer Chemother Pharmacol; 2007 May 30; 59(6):771-9. PubMed ID: 17256136
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
    Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J, Svensson SE.
    Clin Endocrinol (Oxf); 2006 Dec 30; 65(6):760-6. PubMed ID: 17121527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.